申请人:Blake F. James
公开号:US20070197537A1
公开(公告)日:2007-08-23
Compounds of Formula I and pharmaceutically acceptable salts thereof, are useful for inhibiting receptor tyrosine kinases and for treating disorders mediated thereby. Methods of using compounds of Formula I and pharmaceutically acceptable salts thereof, for in vitro, in situ, and in vivo diagnosis, prevention or treatment of such disorders in mammalian cells, or associated pathological conditions are disclosed.
公式I的化合物及其药用盐可用于抑制受体酪氨酸激酶,并用于治疗由此介导的疾病。公开了使用公式I的化合物及其药用盐的方法,用于体外、原位和体内诊断、预防或治疗哺乳动物细胞中的这类疾病,或相关的病理情况。